You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Quick question regarding the Malignant Cell State A and Malignant Cell State B. Can you clarify what the differences are between these, and how they are calculated? Are they comparable across samples? (ie, malignant state A is the same for sample 1 and sample 2, or do they differ based on sample-specific factors?)
I assumed they were based on shared copy number profiles for the sample, but not necessarily comparable across samples. Just wanted to double check.
Thanks in advance!
The text was updated successfully, but these errors were encountered:
Malignant Cell States are identified from the clustering results of inferred malignant cell regions based on their expression profiles rather than copy number profiles. Thus, different Malignant Cell States have various function phenotypes. They are not comparable across samples because each ST sample was analyzed independently.
Hi SpaCET team,
Quick question regarding the Malignant Cell State A and Malignant Cell State B. Can you clarify what the differences are between these, and how they are calculated? Are they comparable across samples? (ie, malignant state A is the same for sample 1 and sample 2, or do they differ based on sample-specific factors?)
I assumed they were based on shared copy number profiles for the sample, but not necessarily comparable across samples. Just wanted to double check.
Thanks in advance!
The text was updated successfully, but these errors were encountered: